Quantcast

Latest Pharmaceutical sciences Stories

2014-09-30 23:11:13

MarketOptimizer.org adds “Pericarditis Global Clinical Trials Review, H2, 2014” to its store. This report provides elemental information and data relating to the clinical trials on Pericarditis. Dallas, Texas (PRWEB) September 30, 2014 Clinical trial report, “Pericarditis Global Clinical Trials Review, H2, 2014″ provides data on the Pericarditis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pericarditis. It includes...

2014-09-30 23:09:52

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced a full agenda for the 25th Annual CPhI Worldwide Exhibition to be held in Paris, France, from October 6th to 9th. Somerset, N.J. (PRWEB) September 30, 2014 Catalent Pharma Solutions (Stand 2C9), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and...

2014-09-30 23:06:10

MarketOptimizer.org adds “Hyperemia Global Clinical Trials Review, H2, 2014” to its store. This report provides elemental information and data relating to the clinical trials on Hyperemia. Dallas, Texas (PRWEB) October 01, 2014 Clinical trial report, “Hyperemia Global Clinical Trials Review, H2, 2014″ provides data on the Hyperemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperemia. It includes an overview of...

2014-09-30 23:04:46

MarketOptimizer.org adds “Idiopathic (Essential) Hypertension Global Clinical Trials Review, H2, 2014” to its store. This report provides elemental information and data relating to the clinical trials on Idiopathic (Essential) Hypertension. Dallas, Texas (PRWEB) October 01, 2014 Clinical trial report, “Idiopathic (Essential) Hypertension Global Clinical Trials Review, H2, 2014″ provides data on the Idiopathic (Essential) Hypertension clinical trial scenario. This report provides...

2014-09-30 23:03:49

MarketOptimizer.org adds “Occlusive Arterial Disease (OAD) Global Clinical Trials Review, H2, 2014” to its store. This report provides elemental information and data relating to the clinical trials on Occlusive Arterial Disease (OAD). Dallas, Texas (PRWEB) October 01, 2014 Clinical trial report, “Occlusive Arterial Disease (OAD) Global Clinical Trials Review, H2, 2014″ provides data on the Occlusive Arterial Disease (OAD) clinical trial scenario. This report provides elemental...

2014-09-30 20:23:13

OTTAWA, Sept. 30, 2014 /CNW/ - Protecting the health and safety of Canadians is our government's highest priority. Our expectation is that Health Canada uses the appropriate powers and tools at its disposal to help ensure that the drugs Canadians need meet the highest safety and quality standards. To that end, Health Canada has taken decisive action today to stop the import into Canada of all drug products from three plants in India. They are: -- Apotex Pharmachem India Pvt Ltd --...

2014-09-30 20:23:12

OTTAWA, Sept. 30, 2014 /CNW/ - Health Canada took action today to stop the import of health products from the following sites in India: -- Apotex Pharmachem India Pvt Ltd (APIPL) -- Apotex Research Private Limited (ARPL) -- IPCA Laboratories The action applies to finished products from ARPL, as well as active pharmaceutical ingredients (APIs) and products made with APIs from APIPL and IPCA. Health Canada has compiled an initial list of products affected by the import ban....

2014-09-30 16:28:04

Growth Capital Allows Alimera to Fulfill Its Milestone Obligation Triggered by FDA Approval of ILUVIEN® ATLANTA, Sept. 30, 2014 /PRNewswire/ -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that it has received a $25 million advance from Hercules Technology Growth Capital, Inc. (NYSE: HTGC) (Hercules). The payment is the second...

2014-09-30 16:24:50

LONDON, Sept. 30, 2014 /PRNewswire/ -- STUDY OBJECTIVESA drug delivery system is one of the very important aspects in today's growth in the pharmaceutical industry. BCC Research's goal in steering this study is to provide an overview of the current and future characteristics of the market for these drug delivery systems. The key objective is to present a comprehensive analysis and future direction of these drug delivery systems as an important tool in improving the efficacy and...

2014-09-30 16:24:37

NEW YORK, Sept. 30, 2014 /PRNewswire/ -- STUDY OBJECTIVESThe objective of BCC in conducting this study is to provide an overview of the current and future characteristics of the global market for protein drugs/therapeutics. The key objective is to present a comprehensive analysis and future direction of protein drugs as an important tool in the treatment of various diseases.This report explores present and future strategies within the protein therapeutics market, which includes...


Latest Pharmaceutical sciences Reference Libraries

Phytotherapy Research
2012-05-01 10:17:25

Phytotherapy Research is a monthly peer-reviewed scientific journal publishing original research papers, short communications, reviews, and letters on medicinal plant research. Topics include pharmacology, toxicology, and the clinical applications of herbs and natural products in medicine, from case histories to clinical trials, including studies of herb-drug interactions and other aspects of the safety of herbal medicines. Short communications dealing with the pharmacology and screening...

More Articles (1 articles) »
Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related